CN101717446A - 抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 - Google Patents
抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 Download PDFInfo
- Publication number
- CN101717446A CN101717446A CN200910153897A CN200910153897A CN101717446A CN 101717446 A CN101717446 A CN 101717446A CN 200910153897 A CN200910153897 A CN 200910153897A CN 200910153897 A CN200910153897 A CN 200910153897A CN 101717446 A CN101717446 A CN 101717446A
- Authority
- CN
- China
- Prior art keywords
- prrsv
- antibody
- yolk
- protein
- igy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 25
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 16
- 239000000427 antigen Substances 0.000 claims abstract description 9
- 102000036639 antigens Human genes 0.000 claims abstract description 9
- 108091007433 antigens Proteins 0.000 claims abstract description 9
- 241001465754 Metazoa Species 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 24
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 19
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 19
- 238000005406 washing Methods 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 13
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000010790 dilution Methods 0.000 claims description 10
- 239000012895 dilution Substances 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000010166 immunofluorescence Methods 0.000 claims description 9
- 235000015097 nutrients Nutrition 0.000 claims description 9
- 235000020183 skimmed milk Nutrition 0.000 claims description 9
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 9
- 239000000839 emulsion Substances 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 238000001262 western blot Methods 0.000 claims description 8
- 238000012870 ammonium sulfate precipitation Methods 0.000 claims description 7
- 230000014509 gene expression Effects 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 241000287828 Gallus gallus Species 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 108060003951 Immunoglobulin Proteins 0.000 claims description 5
- 238000013016 damping Methods 0.000 claims description 5
- 238000003113 dilution method Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 102000018358 immunoglobulin Human genes 0.000 claims description 5
- 238000009010 Bradford assay Methods 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 238000001042 affinity chromatography Methods 0.000 claims description 4
- 238000004945 emulsification Methods 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 230000005847 immunogenicity Effects 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 230000009465 prokaryotic expression Effects 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000010612 desalination reaction Methods 0.000 claims description 3
- 230000000249 desinfective effect Effects 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 230000002163 immunogen Effects 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 108091008146 restriction endonucleases Proteins 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 210000001534 vitelline membrane Anatomy 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 241000700605 Viruses Species 0.000 abstract description 14
- 230000036039 immunity Effects 0.000 abstract description 6
- 241000124008 Mammalia Species 0.000 abstract description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract description 5
- 230000007423 decrease Effects 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 3
- 230000000295 complement effect Effects 0.000 abstract description 2
- 230000000704 physical effect Effects 0.000 abstract description 2
- 102000009109 Fc receptors Human genes 0.000 abstract 1
- 108010087819 Fc receptors Proteins 0.000 abstract 1
- 102000006395 Globulins Human genes 0.000 abstract 1
- 108010044091 Globulins Proteins 0.000 abstract 1
- 206010029719 Nonspecific reaction Diseases 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 11
- 102100034613 Annexin A2 Human genes 0.000 description 7
- 108090000668 Annexin A2 Proteins 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 101710141454 Nucleoprotein Proteins 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 2
- 101710110895 Uncharacterized 7.3 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000001524 infective effect Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 230000008521 reorganization Effects 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical class C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241001292006 Arteriviridae Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 101710091045 Envelope protein Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101150001779 ORF1a gene Proteins 0.000 description 1
- 101710087110 ORF6 protein Proteins 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 101710188315 Protein X Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 102100021696 Syncytin-1 Human genes 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- 241000710914 Totivirus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 description 1
- 210000002718 aborted fetus Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000001132 alveolar macrophage Anatomy 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 102000035122 glycosylated proteins Human genes 0.000 description 1
- 108091005608 glycosylated proteins Proteins 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101538970A CN101717446B (zh) | 2009-11-17 | 2009-11-17 | 抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101538970A CN101717446B (zh) | 2009-11-17 | 2009-11-17 | 抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101717446A true CN101717446A (zh) | 2010-06-02 |
CN101717446B CN101717446B (zh) | 2012-03-14 |
Family
ID=42432089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101538970A Expired - Fee Related CN101717446B (zh) | 2009-11-17 | 2009-11-17 | 抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101717446B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101915846A (zh) * | 2010-08-13 | 2010-12-15 | 扬州大学 | 检测猪繁殖与呼吸综合征病毒的elisa试剂盒及使用方法 |
CN102977184A (zh) * | 2012-11-13 | 2013-03-20 | 天津耀宇生物技术有限公司 | 家蚕蚕蛹中30kD蛋白群的纯化方法 |
CN103421832A (zh) * | 2012-12-04 | 2013-12-04 | 武汉市畜牧兽医科学研究所 | 包含氟苯尼考耐药基因蛋白的卵黄抗体及制备与应用 |
CN103694348A (zh) * | 2013-12-10 | 2014-04-02 | 刘聚祥 | 一种治疗猪病毒性腹泻生物制剂的制备和应用方法 |
CN104277107A (zh) * | 2014-10-11 | 2015-01-14 | 中国农业大学 | 一种沃尼妙林卵黄抗体的制备方法 |
CN105906713A (zh) * | 2016-04-01 | 2016-08-31 | 南阳师范学院 | 一种猪elf4蛋白卵黄抗体的制备方法 |
CN109182364A (zh) * | 2018-08-30 | 2019-01-11 | 武汉百意欣生物技术有限公司 | 一种特异性识别蛋白a的多克隆抗体及其制备方法和应用 |
CN109557316A (zh) * | 2018-12-03 | 2019-04-02 | 湖北省农业科学院畜牧兽医研究所 | 一种鸭坦布苏卵黄抗体的检测方法 |
CN111471104A (zh) * | 2020-04-29 | 2020-07-31 | 西北农林科技大学 | 一种prrsv广谱中和单克隆抗体及其应用 |
CN111500598A (zh) * | 2020-05-08 | 2020-08-07 | 华南农业大学 | 一种检测欧洲型prrsv抗体效价的试剂盒及检测方法 |
CN111579795A (zh) * | 2020-05-15 | 2020-08-25 | 安徽中起生物科技有限公司 | 猪蓝耳病毒GP5蛋白IgY抗体检测免疫荧光试纸及其制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060153855A1 (en) * | 2002-10-30 | 2006-07-13 | Garzon Jose A M | Prevention and treatment of the porcine reproductive and respiratory syndrome (PRRS) |
WO2006091824A2 (en) * | 2005-02-25 | 2006-08-31 | Idexx Laboratories, Inc. | Peptides for detection of antibody to porcine reproductive respiratory syndrome virus |
-
2009
- 2009-11-17 CN CN2009101538970A patent/CN101717446B/zh not_active Expired - Fee Related
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101915846A (zh) * | 2010-08-13 | 2010-12-15 | 扬州大学 | 检测猪繁殖与呼吸综合征病毒的elisa试剂盒及使用方法 |
CN102977184A (zh) * | 2012-11-13 | 2013-03-20 | 天津耀宇生物技术有限公司 | 家蚕蚕蛹中30kD蛋白群的纯化方法 |
CN102977184B (zh) * | 2012-11-13 | 2014-07-09 | 天津耀宇生物技术有限公司 | 家蚕蚕蛹中30kD蛋白群的纯化方法 |
CN103421832A (zh) * | 2012-12-04 | 2013-12-04 | 武汉市畜牧兽医科学研究所 | 包含氟苯尼考耐药基因蛋白的卵黄抗体及制备与应用 |
CN103694348A (zh) * | 2013-12-10 | 2014-04-02 | 刘聚祥 | 一种治疗猪病毒性腹泻生物制剂的制备和应用方法 |
CN104277107A (zh) * | 2014-10-11 | 2015-01-14 | 中国农业大学 | 一种沃尼妙林卵黄抗体的制备方法 |
CN105906713A (zh) * | 2016-04-01 | 2016-08-31 | 南阳师范学院 | 一种猪elf4蛋白卵黄抗体的制备方法 |
CN105906713B (zh) * | 2016-04-01 | 2019-08-16 | 南阳师范学院 | 一种猪elf4蛋白卵黄抗体的制备方法 |
CN109182364A (zh) * | 2018-08-30 | 2019-01-11 | 武汉百意欣生物技术有限公司 | 一种特异性识别蛋白a的多克隆抗体及其制备方法和应用 |
CN109557316A (zh) * | 2018-12-03 | 2019-04-02 | 湖北省农业科学院畜牧兽医研究所 | 一种鸭坦布苏卵黄抗体的检测方法 |
CN111471104A (zh) * | 2020-04-29 | 2020-07-31 | 西北农林科技大学 | 一种prrsv广谱中和单克隆抗体及其应用 |
CN111471104B (zh) * | 2020-04-29 | 2022-03-25 | 西北农林科技大学 | 一种prrsv广谱中和单克隆抗体及其应用 |
CN111500598A (zh) * | 2020-05-08 | 2020-08-07 | 华南农业大学 | 一种检测欧洲型prrsv抗体效价的试剂盒及检测方法 |
CN111579795A (zh) * | 2020-05-15 | 2020-08-25 | 安徽中起生物科技有限公司 | 猪蓝耳病毒GP5蛋白IgY抗体检测免疫荧光试纸及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101717446B (zh) | 2012-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101717446B (zh) | 抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 | |
CN101661042B (zh) | 猪繁殖与呼吸综合征病毒双抗体夹心elisa试剂盒 | |
Oleksiewicz et al. | Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes | |
KR20010012337A (ko) | 백신 또는 진단방법에서 사용하기 위한 피알알에스바이러스의 피알알에스브이 항원부위 인식성 펩타이드 서열 | |
CN104862285B (zh) | 猪流行性腹泻病毒抗体捕获elisa检测方法及应用 | |
Liu et al. | Serological assays to discriminate rabbit haemorrhagic disease virus from Australian non-pathogenic rabbit calicivirus | |
CN105296441B (zh) | 一种牛病毒性腹泻病毒毒株及其应用 | |
CN110873792B (zh) | 非洲猪瘟病毒抗体检测试剂盒 | |
Jiménez de Oya et al. | Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses | |
CN110004178A (zh) | 一种牛病毒性腹泻病毒样颗粒的制备的制备方法 | |
CN110068686A (zh) | 一种伪狂犬病抗体阻断检测试纸 | |
CN103555680A (zh) | 一种具有免疫原性的prrsv病毒样颗粒及其制备与应用 | |
Wang et al. | Development and evaluation of a competitive ELISA using a monoclonal antibody for antibody detection after goose parvovirus virus-like particles (VLPs) and vaccine immunization in goose sera | |
Sun et al. | Attempts to enhance cross-protection against porcine reproductive and respiratory syndrome viruses using chimeric viruses containing structural genes from two antigenically distinct strains | |
CN105348386B (zh) | 抗***o型病毒的单克隆抗体组合及检测试剂盒 | |
CN108559754B (zh) | 一种猪繁殖与呼吸综合征病毒gp5基因修饰的重组蛋白及其应用 | |
Meng et al. | Production and characterization of a monoclonal antibody against spike protein of transmissible gastroenteritis virus | |
CN101955531A (zh) | 检测猪繁殖与呼吸综合征病毒的抗体 | |
CN105968175A (zh) | 一种重组小反刍兽疫病毒n蛋白及其表达方法和应用 | |
JPH05509225A (ja) | C型ロタウイルス培養体およびその利用法 | |
CN109959788A (zh) | 一种用于检测猪伪狂犬病病毒gE抗体的包被抗原和酶标抗体及阻断法试剂盒 | |
CN105296435B (zh) | 杂交瘤细胞株及其分泌的抗***o型(o/gx/09-7)病毒的特异性单克隆抗体与应用 | |
CN1477108A (zh) | 重组gE蛋白及其在诊断伪狂犬病毒感染中的应用 | |
CN103882051B (zh) | 一种检测猪瘟病毒抗体的elisa方法及检测试剂盒 | |
CN102731661A (zh) | 一种检测猪繁殖与呼吸综合症病毒血清抗体的多重表位融合抗原及其制备的试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Xiaoliang Inventor after: Fang Weihuan Inventor after: Wan Xiaoyuan Inventor before: Li Xiaoliang Inventor before: Fang Weihuan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI XIAOLIANG FANG WEIHUAN TO: LI XIAOLIANG FANG WEIHUAN WAN XIAOYUAN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20100602 Assignee: HANGZHOU JIANLIANG VETERINARY BIOLOGICAL PREPARATIONS CO., LTD. Assignor: Zhejiang University Contract record no.: 2013330000373 Denomination of invention: Preparation for PRRSV-N-IgY antibody and application thereof in detecting PRRSV Granted publication date: 20120314 License type: Exclusive License Record date: 20131213 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120314 Termination date: 20151117 |
|
EXPY | Termination of patent right or utility model |